Home › Meningioma › Ohio
Meningioma clinical trials in Ohio
7 studies for Meningioma are looking for participants at sites in Ohio.
Cities in Ohio
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
- Strecker Cancer Center-Belpre, Belpre
- Adena Regional Medical Center, Chillicothe
- University of Cincinnati Cancer Center-UC Medical Center, Cincinnati
- and 30 more
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT02523014A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
- The Ohio State University College of Medicine (OSUCOM), Columbus
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT07428616RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma
- Ohio State University Comprehensive Cancer Center, Columbus
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT07150806Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
- Mayfield Brain and Spine, Cincinnati
- Kettering Health, Kettering
RecruitingObservational study
All ages · All sexes · Updated Jul 22, 2026 · NCT04427384Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Cincinnati Children's Hospital Medical Center, Cincinnati
- Nationwide Children's Hospital, Columbus
RecruitingPhase 1/2
Ages 4 to 39 · All sexes · Updated Jul 20, 2026 · NCT05278208Cognitive Status After Removal of Skull Base Meningioma
- Ohio State University Wexner Medical Center, Columbus
RecruitingObservational study
Ages 18 to 89 · All sexes · Updated May 22, 2026 · NCT04635657Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors
- UH Cleveland Medical Center, Cleveland
- Ohio State University, Columbus
RecruitingPhase 1/2
Ages 18 to 90 · All sexes · Updated May 14, 2026 · NCT05636618From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.